共 50 条
- [1] Triple carcinomas detected in two patients with anti-transcription intermediary factor 1γ (TIF1γ) antibody-positive dermatomyositis European Journal of Dermatology, 2022, 32 : 285 - 287
- [6] Clinical features of anti-transcription intermediary factor 1γ (TIF1γ)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer-associated dermatomyositis JOURNAL OF DERMATOLOGY, 2020, 47 (12): : 1395 - 1402
- [8] Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis FRONTIERS IN IMMUNOLOGY, 2022, 13
- [9] A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody" JOURNAL OF DERMATOLOGY, 2023, 50 (01): : E39 - E40